HYDERABAD, India, August 5, 2016 /PRNewswire/ --
- India's Most Comprehensive Analytical, Lab, Pharma Machineryand Contract Services Event in the Pharmaceutical Capital of India, Hyderabad
- Over 150 Participating Exhibitors From all
- Power-packed and Industry Focussed Conference with Eminent Industry Experts
UBM India, organisers of CPhI and P-MEC India, the leading global pharma trade show and conference, today hosted the 3rd edition of PharmaLytica 2016 (5th - 6th August). The two-day event was inaugurated today by Dr. PV Appaji, Director General, Pharmexcil; Mr. Partha Sarathi Reddy, Chairman and Managing Director, Hetero Drugs; Mr. AVS Chakravarthi, CEO and Managing Director, Ecobliss India Pvt Ltd; Dr. Rao Vadlamudi, President, Indian Pharmaceutical Association (IPA) and Mr. Yogesh Mudras, Managing Director, UBM India at the HITEX Exhibition Center.
(Photo: http://photos.prnewswire.com/prnh/20160805/395944 )
(Photo: http://photos.prnewswire.com/prnh/20160805/395943 )
(Logo: http://photos.prnewswire.com/prnh/20160713/10150475 )
(Logo: http://photos.prnewswire.com/prnh/20130226/599595-c )
Backed by proven expertise of growing businesses in India's Pharma sector, PharmaLytica has been able to create an ideal platform for the pharma industry experts from analytical and biotech, lab equipment and lab chemicals, pharma machinery and outsourcing solutions background. The event is being held in the rich and conducive pharmaceutical capital of India, Hyderabad, which is considered to be the best bulk drug hub in the country and accounts for nearly a fifth of India's exports of drugs.
Through an entire range of sessions and discussions as part of the PharmaLytica conference, the event has been able to help the pharmaceutical community stay updated with the latest industry trends and innovations pertaining to the analytical, biotechnology, laboratory, pharma machinery and outsourcing services sector.
The 3rd edition of PharmaLytica has participants from over 150 exhibitors from across the country. Few major participants include, Ingersoll Rand India Ltd., Chemipack India Pvt. Ltd., Kirloskar Co. Ltd., Newtronic Lifecare, Shiv Shakti Process Equipment, GMP Technical Solutions, Integrated Cleanroom Technology, Captech Systems, Galaxy Sivtek, First Source Laboratory Solutions, Polmon Instruments, Osworld Scientific Equipments, Charles River Laboratories - India, Humidity Technologies, Medica Instruments, Jay Instruments & Systems, Daicel Chiral Technologies (India), Scientific Research Instruments Company, Sefar India and Suntec Teknopak Cleanrooms & Containments amongst others.
Speaking at the inauguration of the 3rd edition of the event, Mr. Yogesh Mudras, Managing Director, UBM India said, "Analytical, bio-technology, lab equipment, pharma machinery and outsourcing services in India is set for huge augmentation owing to quality, research, regulatory and environmental compliances. Consequently, the need of the hour for Indian industry players is to optimise the potential of today's landscape with better product and service offerings. To further market these offerings to a wider audience and in-turn stimulate trade amongst this niche Pharma sector, UBM India brings the 3rd edition of PharmaLytica, an industry platform dedicated to analytical, outsourcing, laboratory, pharma machinery and biotechnology sectors. PharmaLytica will not only enable the exhibitors and visitors to network and connect but will also help the pharma community to pick up the latest industry trends and inventions pertaining to these sectors with its power-packed conferences."
He further added, "Being a leader in the Pharma Exhibition space, this year, UBM India is also proud to announce the launch of the 'India Pharma Week' while celebrating a decade of CPhI and P-MEC India. The weeklong event which will be held concurrently at the Bombay Convention and Exhibition Centre (BCEC) and Bandra Kurla Complex (BKC) in Mumbai will host over 10 sub-events which will focus on business, knowledge, leadership, innovation and recognition in the field of pharma, strengthening our foothold in the sector."
Key sessions at PharmaLytica 2016 cover subjects that encompass new trends and insights relating to the sector at large. Day 1 saw sessions on 'Status and Trend of Global Innovative Drugs - The Power of Partnerships and Alliances', 'Contemporary Clinical Trials - Issues and Concerns', 'Good Pharmacovigilance Practice', 'Role of Technology and Health Outcomes: A Peek into the Future', 'Converting Pharmaceutical Innovation into Sustainable Productivity' and 'Diagnostic Clinics - Role of Real World Data'.
Day 2 will include sessions on 'India's Continued Alignment with the Global Pharmaceutical Industry', 'GMP Regulations for Pharma Industry', 'Advancements and Impacts of Analytical and Bioanalytical Techniques', 'Advances in Chromatography and Mass Spectrometry', 'Laboratory Analytical Market - Statusquo and Future', 'Global impact of Industry 4.0 on Pharma Manufacturing' and 'ISA Standards in the Context of the Food and Pharmaceutical industry'.
The sessions have some prominent names from the industry such as Dr. Akhilesh Sharma, Chief Medical Officer and Global Head, Dr Reddy's Laboratories Limited; Dr. Ambrish Srivastava, Vice President: Medical Affairs, Clinical Research and Regulatory, Alkem Labs Ltd.; Dr. Ajoy Roy, Senior Medical Director, Head India Medical Services, Parexel International (India) Pvt. Ltd.; Dr Shubhadeep Sinha, Vice President and Head Global Pharmacovigilance Clinical Development, Hetero Group; Mr. Santosh Shevade, CSE Group Head, Clinical Development, Novartis Healthcare Pvt. Ltd.; Dr. Rashmi Hegde, Director-Medical, Abbott Healthcare India Limited; Dr. Bhavana Bhagat, DGM Drug Safety & Risk Management, Lupin Limited; Dr. Sharad Mankumare, Director of Reference Standard Laboratory, United States of Pharmacopeia (USP), Hyderabad; Dr Hemant Borgaonkar, Technical Consultant, Labindia; Mr. Sivaram PV, Managing Director, B&R Industrial Automation Pvt. Ltd.; Mr. Sharad Karve, General Manager, Schneider Electric and President ISA (International Society for Automation, Hyderabad) and Dr. Keshava Prasad, Faculty Scientist, Institute of Bioinformatics, Bangalore.
The event also features an innovation gallery with eight participating companies showcasing their innovation and latest technology. The participating companies are Biopharmax India Pvt. Ltd., Galaxy Sivtek Pvt. Ltd., Gandhi Automations Pvt. Ltd., Scientific Research Instruments Company Private Limited, POLMON Instruments Pvt. Ltd., S. K. Pharma Machinery Pvt. Ltd., Landsky Engineers Pvt. Ltd. and Orbit Technologies Pvt. Ltd., Hyderabad.
To know more about the event, visit - http://www.ubmindia.in/pharmalytica
UBM India is all set to showcase the country's largest pharma event CPhI and P-MEC, this year in a grand way with 'India Pharma Week'. From a three day exhibition, CPhI and P-MEC India have grown to a show spanning a week and will be held from 17th to 23rd November 2016. India Pharma Week, will hold more than 10 events spread across the city of Mumbai focusing on business, knowledge, leadership, innovation, recognition and networking in the field of pharma.
About UBM India:
UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences and seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in
Media Contact: Mili Lalwani [email protected] 022-61727000 UBM India
Subscribe to our Free Newsletters!
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...